Daily Stock Analysis, BNTC, Benitec Biopharma Ltd, priceseries

Benitec Biopharma Ltd. Daily Stock Analysis
Stock Information
Open
2.03
Close
2.06
High
2.26
Low
2.01
Previous Close
2.06
Daily Price Gain
0.00
YTD High
4.20
YTD High Date
Jan 16, 2018
YTD Low
2.00
YTD Low Date
Jun 19, 2018
YTD Price Change
-0.85
YTD Gain
-29.21%
52 Week High
4.20
52 Week High Date
Jan 16, 2018
52 Week Low
1.85
52 Week Low Date
Jul 7, 2017
52 Week Price Change
0.10
52 Week Gain
5.10%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 13. 2017
1.85
Jan 23. 2017
1.98
5 Trading Days
6.76%
Link
LONG
Mar 29. 2017
2.66
Apr 6. 2017
2.94
6 Trading Days
10.43%
Link
LONG
Oct 2. 2017
2.17
Oct 6. 2017
2.45
4 Trading Days
12.71%
Link
LONG
Oct 11. 2017
2.46
Oct 13. 2017
2.66
2 Trading Days
7.93%
Link
LONG
Oct 17. 2017
2.77
Oct 18. 2017
2.97
1 Trading Days
7.22%
Link
LONG
Jan 3. 2018
3.00
Jan 22. 2018
3.55
12 Trading Days
18.22%
Link
Company Information
Stock Symbol
BNTC
Exchange
NasdaqCM
Company URL
http://www.benitec.com
Company Phone
-
CEO
Gregory C. West
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
-
About

Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene-silencing technology called ddRNAi or RNAi. It operates through the Australia and United States of America geographical segments. The company was founded by Kenneth C. Reed in 1997 and is headquartered in Melbourne, Australia.

Description

Developing gene therapies for hepatitis C based on RNA interference.